Arizona Health Care Cost Containment System Director Jami Snyder approved new treatment options for opioid patients using Medicaid Thursday, after the Pharmacy and Therapeutics Committee recommended the changes last month.
The changes, which were urged by a group of doctors and will go into effect October 1, add a generic buprenorphine sublingual tablet and a buprenorphine injectable that requires prior authorization to the preferred drug list, according to AHCCCS spokeswoman Heidi Capriotti. The drugs help to prevent withdrawal symptoms.
Read more at: https://azcapitoltimes.com/news/2019/06/14/state-medicaid-agency-approves-more-treatment-options-for-opioid-addiction/
Source: Arizona Capitol Times, June 14, 2019
